|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$8,260
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$4,200
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$8,794
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$14,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$17,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$182,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
5R01CA166264-05
|
$307,700
|
$307,700
|
POVIRK, LAWRENCE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
1K08CA218460-01
|
$106,531
|
$53,266
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$403,904
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$9,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$16,333
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$38,090
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$44,460
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
7R00CA207848-04
|
$165,808
|
|
WARREN ANDERSEN, SHANEDA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Virus-targeted therapeutic for EBV-Associated Malignancies
|
5R44CA153474-03
|
$519,583
|
$519,583
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-02
|
$176,231
|
$176,231
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-02S2
|
$25,857
|
$8,533
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-02
|
$341,981
|
$112,854
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$216,417
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
$12,434
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
$1,999
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
$41,488
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
$38,731
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
$16,377
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
4UH3CA206124-03
|
$423,750
|
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation of a rapid point-of-care breath test for breast cancer
|
3R44CA203019-02S1
|
$224,700
|
|
PHILLIPS, MICHAEL
|
MENSSANA RESEARCH, INC.
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$465,962
|
$465,962
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$465,962
|
$232,981
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$17,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$9,536
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$5,300
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$2,224
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-04
|
$379,294
|
$379,294
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
1R21CA208921-01A1
|
$200,807
|
$200,807
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
Using functional genomics to inform gene environment interactions for colorectal cancer
|
3R01CA201407-03S1
|
$23,154
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-04
|
$393,811
|
$393,811
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
5R01CA172921-05
|
$357,673
|
$178,837
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Beta-lapachone for Lung Cancer Chemotherapy
|
5R01CA102792-15
|
$335,140
|
$335,140
|
BOOTHMAN, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$2,436
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$4,800
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$501,079
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-15S1
|
$72,364
|
$11,578
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
5U54CA096300-15
|
$871,799
|
$139,488
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-15S2
|
$400,000
|
$64,000
|
TRAVIS, ELIZABETH
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-15S1
|
$679,977
|
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia
|
5R21CA202488-02
|
$166,931
|
$166,931
|
SWORDS, RONAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
Total relevant funding to Chemotherapy for this search: $334,351,457
|